Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3797514 | 0.75 | — | — | |
| SCHEMBL3989392 | 0.69 | CES1 (0.35) | CES1PTPRC | |
| SCHEMBL2818848 | 0.67 | CES1 (0.37) | CES1PTPRC | |
| SCHEMBL3986724 | 0.65 | CES1 (0.44) | CES1PTPRC | |
| SCHEMBL447698 | 0.63 | — | — | |
| SCHEMBL10536079 | 0.62 | CES1 (0.41) | CES1PTPRC | |
| SCHEMBL20278752 | 0.62 | PTP4A3 (0.42) | — | |
| SCHEMBL9820301 | 0.61 | — | — | |
| SCHEMBL169947 | 0.61 | CES1 (0.35) | CES1PTPRC | |
| SCHEMBL20366857 | 0.61 | CDC25B (0.56) | CES1PTPRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120114459-A | Application of benzofuranpyrimidinone or benzothiophene pyrimidinone compounds | 南京工业大学 | 2025-06-10 | — | — | CN | claimed |
| CN-117800894-A | Saturated cyclic derivative, pharmaceutical composition containing same and medical application of saturated cyclic derivative | 苏州阿尔脉生物科技有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-115142281-B | Dye micro-nanocrystallization method | 安徽工程大学 | 2023-08-18 | — | — | CN | claimed |
| CN-114957282-A | Near-infrared absorption organic small-molecule photovoltaic material based on benzothiophene/fluorine substituted benzothiophene derivative | 东华理工大学 | 2022-08-30 | — | — | CN | claimed |
| US-20190169151-A1 | THERAPEUTIC AURONES | Middle Tennessee State University (US) | 2019-06-06 | — | — | US | claimed |
| EP-3442520-A1 | THERAPEUTIC AURONES | Middle Tennessee State University (US) | 2019-02-20 | — | — | EP | claimed |
| WO-2017180644-A1 | THERAPEUTIC AURONES | Middle Tennessee State University (US) | 2017-10-19 | — | — | WO | claimed |
| EP-2680695-A1 | COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY | Merck Sharp & Dohme Corp. (US) | 2014-01-08 | — | — | EP | claimed |
| WO-2012118679-A1 | COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY | MERCK SHARP & DOHME CORP. (US) | 2012-09-07 | — | — | WO | claimed |
| EP-1877377-A2 | PROCESS FOR PREPARING 3,3-DISUBSTITUTED OXINDOLES AND THIO-OXINDOLES | Wyeth (US) | 2008-01-16 | — | — | EP | claimed |
| WO-2006118955-A2 | PROCESS FOR PREPARING 3,3-DISUBSTITUTED OXINDOLES AND THIO-OXINDOLES | WYETH (US) | 2006-11-09 | — | — | WO | claimed |
| US-20060247441-A1 | Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles | WYETH (US) | 2006-11-02 | — | — | US | claimed |
| WO-1998034995-A1 | COMPOUNDS AND METHODS FOR DOPING LIQUID CRYSTAL HOSTS | QUEEN'S UNIVERSITY AT KINGSTON (CA) | 1998-08-13 | — | — | WO | claimed |
| JP-10087653-A | — | — | None | — | — | JP | disclosed |
| CN-120349290-B | Resist, preparation method, composition, adhesive layer and pattern forming method | 南开大学 | 2026-05-19 | — | — | CN | disclosed |
| EP-4725941-A1 | ARYLAMIDE DERIVATIVE HAVING ANTITUMOR ACTIVITY | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2026-04-15 | — | — | EP | disclosed |
| US-3972895-A | ANIMAL GROWTH REGULATOR, HERBICIDE | AMERICAN CYANAMID COMPANY (US) | 1976-08-03 | — | — | US | disclosed |
| US-3953542-A | CATALYST OF VANADIUM OR TITANIUM HALIDE, ALUMINUM TRIHYDROCARBON, AND A CARBONYL COMPOUND | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1976-04-27 | — | — | US | disclosed |
| US-3948869-A | Process for polymerizing conjugated dienes | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1976-04-06 | — | — | US | disclosed |
| US-3944567-A | ANIMAL GROWTH REGULATOR, HERBICIDE | AMERICAN CYANAMID COMPANY (US) | 1976-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060247441-A1 | Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles | TPMT, TH, HTR3C | CES1 3625/4885PTPRC 1352/4885 |
| US-20190169151-A1 | THERAPEUTIC AURONES | AURKA, PIGS, PRF1 | CES1 1169/4885PTPRC 3037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.